West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 667,700 | 762,600 | 688,000 | 576,200 | 483,700 |
| Receivables | 498,700 | 489,000 | 476,400 | 480,500 | 465,700 |
| Inventories | 416,500 | 378,400 | 353,800 | 345,200 | 310,200 |
| Other current assets | 107,600 | 112,000 | 80,100 | 75,100 | 67,400 |
| TOTAL | $1,690,500 | $1,742,000 | $1,598,300 | $1,477,000 | $1,327,000 |
| Non-Current Assets | |||||
| PPE Net | 1,065,900 | 1,057,500 | 1,006,500 | 973,100 | 930,800 |
| Investments And Advances | 208,100 | 207,700 | 215,700 | 211,700 | 211,900 |
| Intangibles | 130,600 | 132,900 | 135,000 | 137,800 | 138,200 |
| Other Non-Current Assets | 199,600 | 173,700 | 187,100 | 133,900 | 131,800 |
| TOTAL | $1,604,200 | $1,571,800 | $1,544,300 | $1,456,500 | $1,412,700 |
| Total Assets | $3,294,700 | $3,313,800 | $3,142,600 | $2,933,500 | $2,739,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 248,200 | 232,200 | 207,700 | 205,100 | 204,300 |
| Accrued Expenses | 77,500 | 116,300 | 114,000 | 87,700 | 69,900 |
| Other current liabilities | 170,400 | 165,800 | 145,100 | 150,500 | 147,200 |
| TOTAL | $584,800 | $594,100 | $558,600 | $472,600 | $482,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 208,300 | 208,800 | 209,900 | 251,800 | 252,300 |
| aiOther Non-Current Liabilities | 145,800 | 141,700 | 133,300 | 139,600 | 140,900 |
| TOTAL | $383,700 | $384,300 | $381,700 | $428,300 | $427,900 |
| Total Liabilities | $968,500 | $978,400 | $940,300 | $900,900 | $910,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,076 | 74,282 | 74,080 | 73,979 | 73,824 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 2,617,300 | 2,456,700 | 2,335,800 | 2,160,200 | 1,985,400 |
| Other shareholders' equity | -182,800 | -159,100 | -155,500 | -133,400 | -139,900 |
| TOTAL | $2,326,200 | $2,335,400 | $2,202,300 | $2,032,600 | $1,829,000 |
| Total Liabilities And Equity | $3,294,700 | $3,313,800 | $3,142,600 | $2,933,500 | $2,739,700 |